In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Summit Therapeutics Inc’s stock clocked out at $23.50, down -0.09% from its previous closing price of $23.52. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 1.73 million shares were traded. SMMT stock price reached its highest trading level at $24.17 during the session, while it also had its lowest trading level at $22.76.
Ratios:
To gain a deeper understanding of SMMT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.31 and its Current Ratio is at 8.31. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $35.
On December 11, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $30.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $31.Jefferies initiated its Buy rating on December 06, 2024, with a $31 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 30,000 shares of SMMT for $112,500 on Mar 26 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $3.75 per share. On Mar 27 ’24, another insider, Zanganeh Mahkam, who serves as the Chief Executive Officer of the company, bought 26,000 shares for $3.72 each. As a result, the insider paid 96,720 and bolstered with 520,814 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 17330028544 and an Enterprise Value of 16875633664.
Stock Price History:
The Beta on a monthly basis for SMMT is -0.88, which has changed by 5.0 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, SMMT has reached a high of $33.89, while it has fallen to a 52-week low of $2.10. The 50-Day Moving Average of the stock is 23.60%, while the 200-Day Moving Average is calculated to be 68.77%.
Shares Statistics:
It appears that SMMT traded 2.24M shares on average per day over the past three months and 2840450 shares per day over the past ten days. A total of 737.09M shares are outstanding, with a floating share count of 114.59M. Insiders hold about 84.45% of the company’s shares, while institutions hold 11.53% stake in the company. Shares short for SMMT as of 1736899200 were 21521491 with a Short Ratio of 9.62, compared to 1734048000 on 17529194. Therefore, it implies a Short% of Shares Outstanding of 21521491 and a Short% of Float of 18.110001.
